ArticleDigestive diseases and sciences2010
The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey.
Article in Digestive diseases and sciences, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Illness experience and needs in children with inflammatory bowel disease: a systematic review and meta-synthesis of qualitative studies.BMC pediatrics · 2026Pooled it
- Efficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of Published Placebo-Controlled Trials.Gut and liver · 2016Pooled it
- Pooled it
- Patient views about the impact of ulcerative colitis and its management with drug treatment and surgery: a nested qualitative study within the CONSTRUCT trial.BMC gastroenterology · 2019Trial
- Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study.Journal of Crohn's & colitis · 2016Trial
- Longitudinal results of cognitive behavioral treatment for youths with inflammatory bowel disease and depressive symptoms.Journal of clinical psychology in medical settings · 2012Trial
- Microbiome-Based Therapies in Ulcerative Colitis: Mechanisms, Clinical Evidence, and a Precision-Medicine Framework.Biomedicines · 2026Article
- Quality of Life in Patients with Inflammatory Bowel Diseases Is Associated with Affective Temperament Traits: A Cross-Sectional Survey of a Polish Clinical Sample.Journal of clinical medicine · 2025Article
- The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis.Inflammatory bowel diseases · 2024Article
- Socio-psychological factors associated with anticipated stigma toward COVID-19: a cross-sectional study in Japan.BMC public health · 2023Article
- What are IBD Patients Talking About on Twitter? Using Natural Language Understanding to Investigate Patients' Tweets.SN computer science · 2023Article
- Identifying Patients With Inflammatory Bowel Disease on Twitter and Learning From Their Personal Experience: Retrospective Cohort Study.Journal of medical Internet research · 2022Article
- Incorporating patient experience into drug development for ulcerative colitis: development of the Urgency Numeric Rating Scale, a patient-reported outcome measure to assess bowel urgency in adults.Journal of patient-reported outcomes · 2022Article
- Aloe vera gel attenuates acetic acid-induced ulcerative colitis in adult male Wistar rats.Toxicology reports · 2022Article
- The effect of the online eye movement desensitization and reprocessing early intervention protocol (EMDR R-TEP) for the risk groups with post-traumatic stress symptoms during the COVID-19 pandemic.Frontiers in psychology · 2022Article
- Patient knowledge of fecal calprotectin in inflammatory bowel disease (IBD): An observational study in Mexico.F1000Research · 2020Article
- Real-world data about emotional stress, disability and need for social care in a German IBD patient cohort.PloS one · 2020Article
- Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation.BMJ open gastroenterology · 2019Article
- Optimizing the multidimensional aspects of the patient-physician relationship in the management of inflammatory bowel disease.Intestinal research · 2018Article
- Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom.The European journal of health economics : HEPAC : health economics in prevention and care · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study was designed to identify the impact chronic ulcerative colitis (UC) has on the lives of patients compared to other chronic conditions. Overall, 451 patients with UC, 309 with rheumatoid arthritis, 305 with asthma, and 305 with migraine headaches were recruited in an Internet survey designed to assess a variety of disease-impact indices.
resultsPatients with UC reported a mean of eight (self-defined) flare-ups in the previous 12 months. Significantly more patients with UC (81%) believed that the quantity of flare-ups they experienced was 'normal', compared to patients with migraine headaches (64%) or asthma (75%). Patients with UC also reported significantly more worry about disease complications (84%), depression (62%), and embarrassment (70%) than patients with the other chronic conditions.
conclusionsCompared to patients with other chronic conditions, patients with UC perceive substantially more negative impact upon their lives, especially with regard to the psychological burden.
Indexed as
Identifiers
20155319What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.